• A recent clinical trial has started evaluating the safety and tolerability of a novel therapy involving a virus that can infect and kill human cancer cells.
• The novel therapy called Vaxinia can reduce the size of a broad range of cancers in animal and laboratory models at low doses.
• This new therapy has considerable promise due to its selective targeting of cancer cells and its ability to target a broad array of advanced-stage cancers.

Written by Deep Shukla on June 2, 2022 — Fact checked by Jennifer Chesak

read full article